Short Interest in Ainos, Inc. (NASDAQ:AIMD) Rises By 1,959.7%

Ainos, Inc. (NASDAQ:AIMD) was the target of a large increase in short interest during the month of January. As of January 30th, there was short interest totaling 364,031 shares, an increase of 1,959.7% from the January 15th total of 17,674 shares. Based on an average daily trading volume, of 3,475,966 shares, the days-to-cover ratio is presently 0.1 days. Currently, 8.4% of the company’s stock are short sold. Currently, 8.4% of the company’s stock are short sold. Based on an average daily trading volume, of 3,475,966 shares, the days-to-cover ratio is presently 0.1 days.

Insider Activity

In other Ainos news, major shareholder Carbon Nano Technology Taiwan sold 46,000 shares of Ainos stock in a transaction on Wednesday, January 28th. The shares were sold at an average price of $2.17, for a total value of $99,820.00. Following the sale, the insider directly owned 989,925 shares in the company, valued at approximately $2,148,137.25. The trade was a 4.44% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Insiders have sold 47,281 shares of company stock valued at $102,152 in the last 90 days. 9.79% of the stock is owned by company insiders.

Institutional Investors Weigh In On Ainos

A hedge fund recently bought a new stake in Ainos stock. Two Sigma Investments LP purchased a new stake in Ainos, Inc. (NASDAQ:AIMD) during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 23,008 shares of the company’s stock, valued at approximately $80,000. Two Sigma Investments LP owned 0.48% of Ainos as of its most recent filing with the Securities & Exchange Commission.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Ainos in a research report on Monday, December 29th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company has an average rating of “Sell”.

Ainos Stock Down 5.9%

Shares of NASDAQ AIMD opened at $1.74 on Thursday. The firm has a market cap of $8.37 million, a PE ratio of -0.44 and a beta of 2.50. The company has a 50 day simple moving average of $1.97 and a 200 day simple moving average of $2.80. The company has a debt-to-equity ratio of 1.10, a current ratio of 2.96 and a quick ratio of 2.67. Ainos has a 1 year low of $1.61 and a 1 year high of $4.50.

Ainos (NASDAQ:AIMD) last posted its quarterly earnings data on Thursday, November 13th. The company reported ($0.64) earnings per share for the quarter. The company had revenue of $0.00 million during the quarter.

About Ainos

Ainos, Inc (NASDAQ: AIMD) is a clinical‐stage biopharmaceutical company dedicated to developing inhalation therapies for patients with chronic pulmonary disorders. The company’s proprietary platform centers on a dry powder inhalation technology designed to deliver therapeutic agents directly to the lungs, potentially improving drug distribution and reducing systemic side effects compared to traditional oral or intravenous formulations.

The lead product candidate, AI‐401, is an inhaled formulation of ibuprofen in a dry powder format.